Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.50 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7756493 | 0.87 | POLB (0.75) | POLBPTPN22CYP1A2HSD17B10USP2 | |
| SCHEMBL28853958 | 0.80 | POLB (0.67) | POLBPTPN22CYP1A2HSD17B10USP2 | |
| SCHEMBL29362162 | 0.75 | PTPN22 (0.65) | POLBPTPN22CYP1A2HSD17B10USP2 | |
| SCHEMBL29613822 | 0.75 | PTPN22 (1.00) | POLBPTPN22CYP1A2HSD17B10USP2 | |
| SCHEMBL28853957 | 0.75 | POLB (0.60) | POLBPTPN22MAPTESR1ESR2 | |
| SCHEMBL1187756 | 0.75 | POLB (0.60) | POLBPTPN22CYP1A2HSD17B10CYP2C9 | |
| SCHEMBL15400598 | 0.75 | PTPN22 (0.65) | POLBPTPN22CYP1A2HSD17B10USP2 | |
| SCHEMBL29027 | 0.75 | PTPN22 (0.65) | POLBPTPN22CYP1A2HSD17B10USP2 | |
| Hydrochloric Acid SCHEMBL28347175 | 0.75 | PTPN22 (1.00) | POLBPTPN22CYP1A2HSD17B10USP2 | |
| SCHEMBL28483 | 0.75 | PTPN22 (1.00) | POLBPTPN22CYP1A2HSD17B10USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 803 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3494396-B1 | CHEMILUMINESCENT AND FLUORESCENT SUBSTRATE PADS AND USES THEREOF | PIERCE BIOTECHNOLOGY INC (US) | 2025-06-11 | — | — | EP | claimed |
| CN-119836122-A | Passivation layer, preparation method thereof and perovskite solar cell | 天合光能股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| US-20250034321-A1 | COMPOSITIONS OF EPOXY CURING AGENT INCORPORATING NAPHTHOL AND NAPHTHOL DERIVATIVES | EVONIK OPERATIONS GMBH (DE) | 2025-01-30 | — | — | US | claimed |
| CN-118834119-A | Method for synthesizing bisphenol compound by catalysis of supported ionic liquid | 郑州中科新兴产业技术研究院 | 2024-10-25 | — | — | CN | claimed |
| EP-4413058-A1 | COMPOSITIONS OF EPOXY CURING AGENT INCORPORATING NAPHTHOL AND NAPHTHOL DERIVATIVES | Evonik Operations GmbH (DE) | 2024-08-14 | — | — | EP | claimed |
| CN-118055962-A | Epoxy curing agent composition comprising naphthol and naphthol derivative | 赢创运营有限公司 | 2024-05-17 | — | — | CN | claimed |
| WO-2023057234-A9 | COMPOSITIONS OF EPOXY CURING AGENT INCORPORATING NAPHTHOL AND NAPHTHOL DERIVATIVES | EVONIK OPERATIONS GMBH (DE) | 2024-05-10 | — | — | WO | claimed |
| CN-113549002-B | D-sigma-A configuration compound, synthesis method and application | 西安近代化学研究所 | 2023-12-12 | — | — | CN | claimed |
| CN-113636971-B | D-A spiro framework compound, synthesis method and application | 西安近代化学研究所 | 2023-10-20 | — | — | CN | claimed |
| WO-2023057234-A1 | COMPOSITIONS OF EPOXY CURING AGENT INCORPORATING NAPHTHOL AND NAPHTHOL DERIVATIVES | EVONIK OPERATIONS GMBH (DE) | 2023-04-13 | — | — | WO | claimed |
| EP-0488860-B1 | Method for the production of polyalkoxylated aromatic compounds | RHONE POULENC CHIMIE (FR) | 1995-10-11 | — | — | EP | claimed |
| EP-0653637-A2 | Dry elements, test devices, test kits and methods for chemiluminescent detection of analytes using peroxidase labeled reagents | EASTMAN KODAK COMPANY (US) | 1995-05-17 | — | — | EP | claimed |
| WO-1994023060-A2 | ENHANCEMENT OF CHEMILUMINESCENT REACTIONS | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1994-10-13 | — | — | WO | claimed |
| EP-0210449-B1 | PROLONGED CHEMILUMINESCENCE | MILES INC. (US) | 1993-07-28 | — | — | EP | claimed |
| US-5182213-A | Coupling a Phenylenediamine and a Naphthol | MILES INC. (US) | 1993-01-26 | — | — | US | claimed |
| EP-0504663-A1 | Peroxidase indicator system for basic media | Bayer Corporation (US) | 1992-09-23 | — | — | EP | claimed |
| US-4950588-A | DETECTION OF NUCLEIC ACID HYBRIDS, ANTIBODIES ANTIGENS | MOLECULAR DIAGNOSTICS, INC. (US) | 1990-08-21 | — | — | US | claimed |
| WO-1990006372-A1 | SUBSTRATES FOR PEROXIDASE ASSAYING | MICROPROBE CORPORATION (US) | 1990-06-14 | — | — | WO | claimed |
| EP-0210449-A2 | Prolonged chemiluminescence | MILES INC. (US) | 1987-02-04 | — | — | EP | claimed |
| EP-0116454-A2 | Enhanced luminescent or luminometric assay | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1984-08-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250034321-A1 | COMPOSITIONS OF EPOXY CURING AGENT INCORPORATING NAPHTHOL AND NAPHTHOL DERIVATIVES | SRM, PNMT, NIT2 | POLB 546/4885PTPN22 4686/4885CYP1A2 1220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.